Edmond de Rothschild Holding’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54M Buy
623,261
+5,317
+0.9% +$509K 0.78% 32
2025
Q4
$59.4M Buy
617,944
+15,684
+3% +$1.52M 0.84% 26
2025
Q3
$57.4M Sell
602,260
-31,323
-5% -$2.88M 0.89% 24
2025
Q2
$55.2M Sell
633,583
-47,663
-7% -$4.04M 0.88% 21
2025
Q1
$61.2M Buy
681,246
+6,388
+0.9% +$572K 1.08% 17
2024
Q4
$53.9M Sell
674,858
-37,652
-5% -$3.26M 0.92% 23
2024
Q3
$64.1M Sell
712,510
-120,548
-14% -$10.1M 1.03% 23
2024
Q2
$65.6M Buy
833,058
+38,135
+5% +$3.13M 1.11% 24
2024
Q1
$69.3M Sell
794,923
-39,464
-5% -$3.37M 1.16% 18
2023
Q4
$68.7M Buy
834,387
+112,720
+16% +$8.59M 1.23% 18
2023
Q3
$56.5M Buy
721,667
+41,200
+6% +$3.45M 1.14% 18
2023
Q2
$59.9M Buy
680,467
+15,321
+2% +$1.32M 1.18% 18
2023
Q1
$53.6M Buy
665,146
+50,619
+8% +$4.13M 1.22% 20
2022
Q4
$47.8M Buy
614,527
+271,720
+79% +$22M 1.11% 23
2022
Q3
$27.7M Buy
342,807
+19,091
+6% +$1.72M 0.73% 36
2022
Q2
$29.1M Sell
323,716
-2,652
-0.8% -$269K 0.7% 43
2022
Q1
$36.2M Sell
326,368
-29,358
-8% -$3.1M 0.79% 38
2021
Q4
$36.8M Buy
355,726
+34,071
+11% +$3.95M 0.8% 35
2021
Q3
$40.3M Buy
321,655
+32,603
+11% +$4.22M 0.93% 26
2021
Q2
$35.9M Sell
289,052
-2,430
-0.8% -$305K 0.83% 30
2021
Q1
$34.4M Buy
291,482
+9,268
+3% +$1.09M 0.94% 22
2020
Q4
$33.1M Buy
282,214
+10,004
+4% +$1.1M 1.11% 17
2020
Q3
$28.3M Buy
272,210
+39,656
+17% +$3.98M 1.12% 14
2020
Q2
$21.3M Sell
232,554
-6,618
-3% -$635K 0.88% 29
2020
Q1
$21.6M Buy
239,172
+20,633
+9% +$2.2M 1.13% 22
2019
Q4
$24.8M Buy
218,539
+14,549
+7% +$1.6M 0.98% 28
2019
Q3
$22.2M Sell
203,990
-23,837
-10% -$2.49M 0.89% 30
2019
Q2
$22.2M Sell
227,827
-1,698
-0.7% -$155K 0.83% 34
2019
Q1
$20.9M Buy
229,525
+6,519
+3% +$583K 0.72% 38
2018
Q4
$20.3M Buy
223,006
+61,322
+38% +$5.73M 0.71% 40
2018
Q3
$15.9M Buy
161,684
+15,373
+11% +$1.42M 0.45% 59
2018
Q2
$12.5M Sell
146,311
-28,431
-16% -$2.37M 0.36% 67
2018
Q1
$14M Buy
174,742
+12,189
+7% +$1.01M 0.41% 66
2017
Q4
$13.1M Sell
162,553
-8,553
-5% -$685K 0.38% 73
2017
Q3
$13.3M Buy
171,106
+2,071
+1% +$172K 0.38% 71
2017
Q2
$15M Sell
169,035
-5,597
-3% -$472K 0.42% 67
2017
Q1
$14.1M Buy
174,632
+3,405
+2% +$266K 0.37% 72
2016
Q4
$12.2M Sell
171,227
-10,380
-6% -$815K 0.34% 78
2016
Q3
$15.7M Sell
181,607
-84,506
-32% -$7.36M 0.47% 62
2016
Q2
$23.1M Buy
266,113
+5,610
+2% +$454K 0.74% 37
2016
Q1
$19.5M Sell
260,503
-572,262
-69% -$43.1M 0.62% 51
2015
Q4
$64.1M Sell
832,765
-359,990
-30% -$27.1M 1.7% 10
2015
Q3
$79.8M Sell
1,192,755
-29,203
-2% -$2.15M 1.97% 9
2015
Q2
$90.5M Buy
+1,221,958
New +$93.4M 1.95% 6

Other funds holding MDT

Edmond de Rothschild Holding's MDT Position: Q1 2026 in Review

Edmond de Rothschild Holding increased its Medtronic (MDT) stake by 0.86% in Q1 2026, buying an estimated $509K and bringing the position to 623,261 shares worth $54M. The position accounts for 0.78% of the portfolio, ranked #32.

Edmond de Rothschild Holding first reported a position in MDT in Q2 2015 and has held it in 44 quarters since. The position peaked at $90.5M in Q2 2015. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Edmond de Rothschild Holding held 623,261 shares of Medtronic worth $54M as of Q1 2026.
  • Edmond de Rothschild Holding bought 5,317 Medtronic shares in Q1 2026, an estimated $509K.
  • Medtronic made up 0.78% of Edmond de Rothschild Holding's portfolio in Q1 2026, its #32 holding.
  • Edmond de Rothschild Holding first reported a position in Medtronic in Q2 2015 and has held it in 44 quarters since.
  • Edmond de Rothschild Holding's Medtronic position peaked at $90.5M in Q2 2015.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2026, filed 13 May 2026.